Workflow
卡地纳健康(CAH)
icon
搜索文档
Best Growth Stocks to Buy for February 27th
Zacks Investment Research· 2024-02-27 17:06
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 27:Powell Industries, Inc. (POWL) : This custom-engineered equipment and systems company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.2% over the last 60 days.Powell Industries has a PEG ratio of 1.53 comparedwith 1.58 for the industry. The company possesses a Growth Score of A.Cardinal Health, Inc. (CAH) : This healthcare ser ...
Best Growth Stocks to Buy for February 23rd
Zacks Investment Research· 2024-02-23 22:30
医疗保健公司分析 - Cardinal Health是一家全国性的药品分销商和为药店、医疗保健提供商和制造商提供服务的公司,拥有Zacks Rank 1(强烈买入)[1] - Cardinal Health的PEG比率为0.92,行业平均为2.31,公司的增长评分为A[2] 电能分配公司分析 - Powell Industries是一家为电能分配和控制以及其他关键流程提供高度复杂和集成系统的战略供应商,拥有Zacks Rank 1[3] - Powell Industries的PEG比率为1.46,行业平均为1.57,公司的增长评分为A[4] 投资管理公司分析 - Patria Investments Limited为投资者提供资产管理服务,专注于私募股权基金、基础设施发展基金、共同投资基金、建设性股权基金以及房地产和信贷基金,拥有Zacks Rank 1[5] - Patria Investments Limited的PEG比率为0.81,行业平均为0.82,公司的增长评分为B[6]
New Strong Buy Stocks for February 23rd
Zacks Investment Research· 2024-02-23 21:06
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Iridium Communications (IRDM) : This satellite communications company that offers dedicated commercial global voice and data communications services to both businesses and governments in the U.S. as well as globally, has seen the Zacks Consensus Estimate for its current year earnings increasing 62.1% over the last 60 days.J. Sainsbury (JSAIY) : This company which is a leading UK food retailer with interests in financial services,has see ...
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
Zacks Investment Research· 2024-02-22 23:56
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks S ...
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Zacks Investment Research· 2024-02-19 23:46
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and ...
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Zacks Investment Research· 2024-02-13 02:46
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, it's pretty easy to find cutting-edge growth stocks wit ...
Cardinal Health Board of Directors Approves Quarterly Dividend
Prnewswire· 2024-02-07 05:35
DUBLIN, Ohio, Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2024 to shareholders of record at the close of business on April 1, 2024. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solut ...
Cardinal Health publishes Fiscal 2023 Environmental, Social and Governance (ESG) Report
Prnewswire· 2024-02-06 20:30
文章核心观点 2024年2月6日,卡地纳健康发布2023财年环境、社会和治理(ESG)报告,展示公司为建设更健康、公平未来所做工作,体现ESG优先事项为利益相关者创造长期可持续价值 [1] 报告亮点 赋能员工 - 公司努力营造包容工作场所,让员工展现真实自我,受到公平平等对待 [2] - 加强减少心理健康污名化的工作,增加员工获取心理健康支持服务的机会,还召集公私部门领导探讨心理健康挑战解决方案 [2] 为客户和社区创造价值 - 持续关注提高供应链弹性,确保客户获得所需产品以提供高质量医疗服务 [3] - 通过业务、宣传及基金会工作,帮助员工群体更公平地获得优质医疗服务 [3] - 公司及其基金会提供近2200万美元现金和产品捐赠,员工额外捐赠100万美元,累计志愿服务超54600小时 [3] 可持续和负责任运营 - 自2019财年基准年起,公司将范围1和范围2温室气体(GHG)排放量减少13%,向2030财年减排50%目标迈进,还对范围3温室气体排放进行基线评估并提交科学碳目标待验证 [4] - 在可持续技术业务中开展首次生命周期评估,结果显示再加工压缩袖的碳足迹降低40%,并减少90%的医院废物处理成本 [4] - 持续改进供应商尽职调查计划和供应链映射,提高供应链透明度和商业诚信 [4] 报告相关信息 - 报告按照全球报告倡议组织(GRI)、可持续发展会计准则委员会(SASB)和气候相关财务信息披露工作组(TCFD)框架编制 [5] - 可在CardinalHealth.com/ESGReport查看完整报告 [5] 公司概况 - 卡地纳健康是药品分销商、医疗和实验室产品全球制造商和分销商,以及医疗保健机构绩效和数据解决方案提供商 [5] - 公司经营超50年,业务覆盖超30个国家,全球约有48000名员工 [6]
Cardinal Health (CAH) Buys Specialty Networks to Boost Workflow
Zacks Investment Research· 2024-02-02 00:41
公司收购 - Cardinal Health最近宣布以12亿美元现金收购了Specialty Networks[1] - 这次收购有望为公司在专科治疗领域的扩张创造平台,并为超过11,500名专科提供者创造增加的临床和经济价值[2] - 这次收购表明Cardinal Health战略性地专注于投资以促进公司的专业业务,并提供满足客户和业务重要需求的先进人员、能力和技术[4] 股价表现 - 过去六个月,CAH的股价上涨了19.3%,而行业下跌了2.9%。同期标普500指数增长了7.5%[3] 业务增强 - 通过加强公司的下游提供者关注的分析能力和服务提供,并加快与生物制药生产商的上游数据和研究机会,这次收购增强了Cardinal Health在重要治疗领域的产品组合[5] - 这次收购有望为11,500名专科提供者创造增加的临床和经济价值,其中包括超过1,200家独立医师诊所的7,000多名医生,并增强公司专业业务的能力,同时支持Navista Network的持续建设[6] 专科网络价值 - Specialty Networks通过United Rheumatology、Gastrologix和GastroGPO、UroGPO等多个专科GPO,为独立专科医生和合作伙伴提供临床和财务价值[7] - 借助Specialty Networks的PPS Analytics,医生、研究人员、付款人和政策制定者可以从对电子病历、实践管理、影像和发药系统数据的分析中获得有价值的可操作洞察[8] 市场前景 - 根据Research and Markets的报告,专科制药市场的增长率为39.8%,2023年市值为925亿美元,预计到2030年将超过9655.4亿美元[9]
Cardinal Health(CAH) - 2024 Q2 - Earnings Call Transcript
2024-02-02 00:32
财务数据和关键指标变化 - 总收入增长12%至574亿美元,反映了医药和医疗两个业务部门的增长 [15] - 毛利增长11%至18亿美元,两个业务部门均有贡献 [15] - 营业利润增长20%至5.62亿美元 [15] - 每股收益增长38%至1.82美元 [14] - 经调整自由现金流达10亿美元,全年达20亿美元 [24] 各条业务线数据和关键指标变化 医药业务 - 收入增长12%至535亿美元,主要来自现有客户的品牌和专科药品销售增长 [19] - 利润增长12%至5.18亿美元,主要受益于优质药品和新冠疫苗分销业务 [20] - 普药业务表现良好,体现了销量增长和市场环境稳定 [20] 医疗业务 - 收入增长3%至39亿美元,首次实现两年来的季度收入增长 [22] - 利润增长至7100万美元,主要得益于缓解通胀影响的举措 [23] - 公司正在执行五点计划提升Cardinal Health品牌销量,取得积极进展 [11] 各个市场数据和关键指标变化 - 公司未具体披露各个市场的数据和指标变化 公司战略和发展方向及行业竞争 - 公司正在简化和聚焦业务,并调整企业运营和报告结构 [9] - 医药业务是公司最大和最重要的业务,公司将继续投资加速专科药品业务的下游和上游发展 [40][41] - 公司收购Specialty Networks,将进一步拓展专科业务的能力,为医疗服务提供商、制药商和患者创造价值 [44][45][46][47] - 医疗业务正在执行改善计划,聚焦于全球医疗产品和分销业务,预计将在2024财年实现盈利 [49][50][51][52][53][54] - 公司正在投资发展其他增长业务,如居家医疗解决方案、OptiFreight物流和核医学与精准健康解决方案 [55][56][57][58] 管理层对经营环境和未来前景的评论 - 公司整体业务表现符合预期,维持2024财年7%-9%的利润增长指引 [10] - 医药业务保持强劲表现,普药业务和整体制药需求保持稳定 [10] - 医疗业务的基本面有所改善,正在执行改善计划取得进展 [11] - 公司有信心实现更新后的2024财年每股收益和自由现金流指引 [12] 问答环节重要的提问和回答 问题1 **Stephanie Davis 提问** 询问收购Specialty Networks的业务构成和能力,以及未来交易的整合目标 [64][65][66] **Jason Hollar 回答** Specialty Networks在专科医疗领域的GPO和数据分析技术能力是公司看重的关键所在,可以进一步拓展公司在专科领域的服务能力。公司将投资发展Specialty Networks的业务,以加速实现公司的专科战略 [65][66] 问题2 **Lisa Gill 提问** 询问公司是否仍然致力于医疗业务,以及新的报告结构下医疗业务利润率下调的原因 [71][72] **Jason Hollar 回答** 公司仍然致力于医疗业务,改善计划的目标和时间表没有变化。利润率下调是由于一次性调整因素,但整体改善计划进展良好,公司对该业务的承诺没有改变 [72][73] 问题3 **Eric Percher 提问** 询问医疗业务二季度的一次性调整项目,以及下半年业务改善的具体进度 [83][84] **Aaron Alt 回答** 二季度的一次性调整主要影响了居家医疗解决方案业务,但医疗改善计划的核心执行情况良好,预计下半年随着成本改善和Cardinal Health品牌销量提升,业务将实现显著改善 [84][85]